M-SERTRALINE

mantra pharma inc🇨🇦 Health Canada

Approval Id: 15178ac6bd8f4059
Drug Approval Canada Name: M-SERTRALINE
Product Name: M-SERTRALINE
Status: Marketed
Status Date: 2023-03-20
Original Market Date: 2023-03-20
Din: 02530937
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:16.04.20
Atc Original: N06AB06 SERTRALINE
Atc Name: n 06 ab 06
Aig Number: 0123417003
Company Name: mantra pharma inc
Company Address: 1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3

SERTRALINE (SERTRALINE HYDROCHLORIDE)

25 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

15178ac6bd8f4059

Type

Standard